CME Group (NASDAQ:CME) Price Target Raised to $266.00

CME Group (NASDAQ:CME) had its price objective boosted by The Goldman Sachs Group from $264.00 to $266.00 in a report published on Monday morning,MarketScreener reports. The firm currently has a sell rating on the financial services provider’s stock.

Several other research firms also recently weighed in on CME. UBS Group restated a “neutral” rating and issued a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. Barclays raised their target price on shares of CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Jefferies Financial Group reduced their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Morgan Stanley boosted their price target on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Rothschild & Co Redburn raised their price objective on CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday, November 6th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $297.59.

CME Group Stock Down 1.4%

CME opened at $302.48 on Monday. The stock has a market cap of $109.07 billion, a price-to-earnings ratio of 27.10, a price-to-earnings-growth ratio of 3.34 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The firm’s fifty day moving average is $278.61 and its 200 day moving average is $273.60. CME Group has a fifty-two week low of $244.43 and a fifty-two week high of $309.35.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.CME Group’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.52 EPS. On average, sell-side analysts forecast that CME Group will post 10.49 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director William R. Shepard purchased 251 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The stock was bought at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Institutional investors and hedge funds have recently modified their holdings of the stock. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Asset Dedication LLC grew its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in CME Group in the third quarter valued at about $27,000. FNY Investment Advisers LLC bought a new position in CME Group in the fourth quarter worth about $27,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the fourth quarter valued at about $28,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME launched futures for Cardano, Chainlink and Stellar — expanding its crypto product suite and giving institutional traders additional regulated venues, which can drive incremental trading and clearing fees. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures
• Positive Sentiment: CME plans to launch Single Stock futures on 50+ top U.S. names (Alphabet, Meta, NVIDIA, Tesla, etc.), broadening product scope and offering capital-efficient tools for equity exposures — potential long-term fee diversification. CME Group to Launch Single Stock Futures
• Positive Sentiment: Sources say CME is exploring the first-ever rare earths futures contract — a new commodity product that could capture demand tied to EVs, clean energy and defense supply-chain hedging. CME Group plans to launch first rare earths futures contract – Reuters
• Positive Sentiment: Wedbush highlighted strong clearing volumes in CME’s prediction markets around Super Bowl LX — an operational sign that new product adoption is producing meaningful flow spikes. Wedbush Supports CME Group Prediction Markets as Volumes Surge Around Super Bowl LX
• Positive Sentiment: Institutional buying — Illinois Municipal Retirement Fund increased its CME position (~38k shares, ~65% growth vs prior), signaling continued institutional demand. Fund Update: Illinois Municipal Retirement Fund Just Disclosed New Holdings
• Neutral Sentiment: Analyst / earnings follow-ups — Q4 analyst-question coverage and commentary highlight execution and growth drivers but contain no new guidance; useful for modeling but not immediately price-moving. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Neutral Sentiment: Crypto market write-ups note CME’s crypto futures launches as a tailwind for underlying token interest, but crypto price moves are separate from CME’s fee-based revenue. Cardano price forecast: will ADA breakout or decline further from here?
• Negative Sentiment: Insider selling — Director Dennis Suskind sold 748 shares (~$224k); multiple recent insider sales can be interpreted by some investors as a cautionary signal. SEC Form 4: Dennis Suskind sale
• Negative Sentiment: Rising short interest — recent data showed short interest increased to ~5.2M shares (≈1.4% of float, ~2.8 days-to-cover), which can add downward pressure if sentiment deteriorates further.
• Negative Sentiment: Goldman Sachs nudged its price target to $266 but maintained a sell rating — a notable institutional view that may limit near-term buying interest from some investors. The Goldman Sachs Group Increases CME Group Price Target to $266

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.